Elaine S. Gilmore, M.D., Ph.D.
Specialties
No ratings currently available, see text in Ratings section below for explanation.
Contact
Elaine S. Gilmore, M.D., Ph.D.
View Contact & SchedulingAbout Me
Dr Gilmore received her MD/PhD from the Univeristy of North Carolina at Chapel Hill and completed her residency at Yale-New Haven Hospital.
Certified Specialties
Dermatology - American Board of Dermatology
Credentials
Residency & Fellowship
Fellowship, Dermatology, Yale University School of Medicine. 2006 - 2008
Residency, Dermatology, Yale University School of Medicine. 2004 - 2007
Internship, Internal Medicine, Stanford University Medical Center. 2003 - 2004
Education
MD | University of North Carolina at Chapel Hill. 2003
Awards
Dermatology Foundation Fellowship Grant. 2007
Member of Medical Scientist Training Program (MSTP). 2000
University of North Carolina Travel Grant. 2000
Renaissance Physiology Dept. Travel Award. 2000
John B. Graham Research Society Travel Grant. 1999
John B. Graham Research Society (Inducted). 1997
Howard Holderness Fellowship. 1997 - 1998
NIH Summer Research Training Grant. 1997
Father Hickey, O.P. Chemistry Award. 1996
Senior Award - Highest Cumulative Average in Chemistry. 1996
Senior Award - Highest Cumulative Average in Biology. 1996
Phi Lambda Upsilon. 1996
American Chemical Society Analytical Chemistry Award. 1995
Alpha Epsilon Delta. 1994
American Chemical Society Organic Chemistry Award. 1994
CRC Press Freshman Chemistry Award. 1993
Roddy Foundation Scholarship. 1992 - 1996
Liberal Arts Honors Program. 1992 - 1996
Publications
Journal Articles
Two Nedd4-binding motifs underlie modulation of sodium channel Nav1.6 by p38 MAPK.
Gasser A, Cheng X, Gilmore ES, Tyrrell L, Waxman SG, Dib-Hajj SD.
J Biol Chem. 2010; 8.
A Novel Nav1.7 Mutation Producing Carbamazepine-Responsive Erythromelalgia.
Fischer, T.Z., *Gilmore E.S., Estacion M., Eastman E., Taylor S., Melanson M., Dib-Hajj S.D., and Waxman S.G.
Ann Neurol. 2009; 65(6): 733-41.
A distinct entity in the spectrum of the CD30+ cutaneous lymphoproliferative diseases: oligolesional nodules with pseudoepitheliomatous hyperplasia followed by spontaneous resolution.
Zayour M, Gilmore E, Heald P, Rose M, Poligone B, Lazova R.
Am J Dermatopathol. 2009; 31: 37-43.
Extensive fixed drug eruption secondary to vancomycin.
Gilmore, E. S., Friedman J. and Morrell, D.
Pediatr Dermatol. 2004; 21(5): 600-2.
Local regulation of cystic fibrosis transmembrane regulator and epithelial sodium channel in airway epithelium.
Huang P, Gilmore E, Kultgen P, Barnes P, Milgram S, Stutts MJ.
Proc Am Thorac Soc. 2004; 1(1): 33-7.
Src family kinases mediate epithelial Na+ channel inhibition by endothelin.
Gilmore, E. S., Stutts, M. J., and Milgram, S.L.
J Biol Chem. 2001; 276(45): 42610-7.
Regulation of the Epithelial Na+ Channel by c-Src Family Kinases.
Gilmore, E. S., Milgram, S. L., and Stutts, M. J.
Molecular Biology of the Cell. 1999; 10 Supplement.
Regulation of the Epithelial Na+ by Src Family Kinases.
Gilmore, E. S., Milgram, S. L., and Stutts, M. J.
Pediatric Pulmonology. 1999; 28: S19.
Books
Manual of Dermatologic Therapeutics: With Essentials of Diagnosis (2006)
Chapter: Immunocompromised Patients: HIV- And Non-HIV-Positive. Manual of Dermatologic Therapeutics: With Essentials of Diagnosis
Authors: Gilmore E.S., Kulwichit W
Publisher: Lippincott 2006
Methods in Molecular Medicine: Cystic Fibrosis Methods and Protocols (2002)
Chapter: CFTR regulation of ENaC
Authors: Donaldson, S. H., Poligone, E. G., and Stutts, M. J.
Publisher: Humana Press Inc., Totowa, NJ 2002
Ratings & Comments
At University of Rochester Medicine, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URochester Medicine partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.